ADERIS PHARMACEUTICALS INC has a total of 37 patent applications. Its first patent ever was published in 1994. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AGENEBIO INC, KHONDRION IP B V and EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 8 | |
#3 | Canada | 4 | |
#4 | Australia | 3 | |
#5 | Mexico | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Argentina | 1 | |
#8 | Hong Kong | 1 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | Malaysia | 1 | |
#12 | Norway | 1 | |
#13 | New Zealand | 1 | |
#14 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Martin Pauline L | 12 |
#2 | Minaskanian Gevork | 10 |
#3 | Rippel Keith | 9 |
#4 | Mcdonald Shawn | 6 |
#5 | Gadgil Shrikant | 5 |
#6 | Wheeler William | 5 |
#7 | O'Dell Stephen | 5 |
#8 | Mcafee Donald A | 3 |
#9 | Peck James V | 3 |
#10 | Wysocki Ronald J | 2 |
Publication | Filing date | Title |
---|---|---|
MX2007010984A | Substituted 9-alkyladenines and the use thereof. | |
WO2005025545A2 | Pharmaceutical formulation for controlled release of selodenoson | |
EP1633371A1 | Method of treating atrial fibrillation or atrial flutter | |
US2004204394A1 | Triptolide analogues | |
US6784165B1 | Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines | |
AU1613101A | Improved process for preparing nitrogen-substituted aminotetralins |